AEGiS-GMHC: Treatment briefs: Is a Sale in Wellcome's Future?

Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Treatment briefs: Is a Sale in Wellcome's Future?

Treatment Issues, Vol. 8, No. 11 - December 1994
David Gold

Some analysts are speculating that Wellcome, the United Kingdom-based parent of Burroughs Wellcome, may be sold in the not-too-distant future. They cite recent disappointments for the company, including the failure of valaciclovir to beat SmithKline's famciclovir to market, the inability to obtain rights to Glaxo's 3TC, and the mixed messages coming out about the Vertex/Wellcome protease inhibitor program. More importantly, these analysts suggest, Wellcome is a mid- size drug company without the "critical mass" of research and products in the pipeline that industry giants like Merck, Roche, Glaxo and Pfizer possess. A sale of the company could have a big impact on AIDS research and the many community- based organizations that rely on the company for financial support.

941201
GM081118

Copyright © 1994 - Treatment Issues. Reproduced with permission. Treatment Issues is published twelve times yearly by GMHC, Inc. All rights reserved. Noncommercial reproduction is encouraged. Subscription lists are kept confidential. GMHC Treatment Issues, The Tisch Building, 119 West 24th Street, New York, NY 10011 fredg@gmhc.org http://www.gmhc.org

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .